1.Greengross, S, Murphy, E, Quam, L, Rochon, P. Aging: a subject that must be at the top of world agendas. BMJ 1997;315:1028–9.
2.Avorn, J. Medication use and the elderly: current status and opportunities. Health Affairs Spring 1995;276–86.
3.Sackett, DL, Rosenberg, WMC, Gray, JAM, Haynes, RB, Richardson, WS. Evidence based medicine: what it is and what it isn't. It's about integrating individual clinical expertise and the best external evidence. BMJ 1996;312:71–2.
4.Sibbald, B, Roland, M. Why are randomised controlled trials important? BMJ 1998;316:201.
5.Evidence-Based Medicine Working Group. Evidence-Based Medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420–5.
6.Levin, A. Evidence-based medicine gaining supporters. Ann Intern Med 1998;128:334–6.
7.Charlton, BG. Randomized clinical trials: the worst kind of epidemiology? Nature Medicine 1995;1:1101–2.
8.Taubes, G. Looking for the evidence in medicine. Science 1996;272:22–4.
9.Feinstein, AR, Horwitz, RI. Problems in the evidence of evidence-based medicine. Am J Med 1997;103:529–35.
10.Maynard, A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet 1997;349:126–8.
11.Kerridge, I, Lowe, M, Henry, D. Ethics and evidence based medicine. BMJ 1998;316:1151–3.
12.Naylor, CD. Grey zone of clinical practice: some limits to evidence-based medicine. Lancet 1995;345:840–2.
13.Knottnerus, JA, Dinant, GJ. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997;315:1109–10.
14.Schneider, LS, Olin, JT, Lyness, SZ, Chui, HC. Eligibility of Alzheimer's disease clinic patients for clinical trials. J Am Geriatr Soc 1997;45:923–8.
15.Green, J, Britten, N. Qualitative research and evidence based medicine. BMJ 1998;316:1230–2.
16.Gurwitz, JH, Col, NF, Avorn, J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417–22.
17.Avorn, J. Including elderly people in clinical trials, BMJ 1997;315:1033–4.
18.Bugeja, G, Kumar, A, Banerjee, AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997;315:1059.
19.Lye, M. Access to advances in cardiology. Lancet 1997;350:1162–3.
20.Evans, JG. Evidence-based and evidence-biased medicine. Age-Ageing 1995;24:461–3.
21.Black, N. Developing high quality clinical databases: the key to a new research paradigm. BMJ 1997;315:381–2.
22.Hornberger, J, Wrone, E. When to base clinical policies on observational versus randomized trial data. Ann intern Med 1997;127:697–703.
23.Horwitz, RI, Viscoli, CM, Clemens, JD, Sadock, RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990;89:630–8.
24.Black, N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215–8.
25.Walker, AM. Common language. Pharmacoepidemiol Drug Safety 1996;5:415–8.
26.Engels, EA, Spitz, MR. PACE-setting research. Lancet 1997;350:677–8.
27.Beers, MH, Ouslander, JG, Fingold, SG, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992;117:684–9.
28.Willcox, SM, Himmelstein, DU, Woolhandler, S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292–6.
29.Rubenstein, LZ. An overview of comprehensive geriatric assessment: rationale, history, program models, basic components. In: Rubenstein, LZ, Wieland, D, Bernabei, R, eds. Geriatric assessment technology: the state of the art. Milano, Italia: Kurtis; 1995:11–26.
30.Avorn, J, Gurwitz, JH. Drug use in the nursing home. Ann Intern Med 1995;123:195–204.
31.Beers, MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531–6.
32.Bernabei, R, Gambassi, G, Mor, V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc 1998;46:250–2.
33.Bernabei, R, Gambassi, G, Lapane, K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol Med Sci 1999;54:M25–33.
34.Morris, JN, Hawes, C, Fries, BE et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990;30:293–7.
35.Gambassi, G, Landi, F, Peng, L, et al. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care 1998;36:167–79.
36.Bernabei, R, Gambassi, G, Lapane, K, et al. Management of pain in elderly cancer patients. JAMA 1998;279:1877–82.
37.Gambassi, G, Lapane, K, Sgadari, A, et al. Prevalence, clinical correlates and treatment of hypertension in institutionalized elderly. Arch Intern Med 1998;158:2377–85.
38.Landi, F, Gambassi, G, Lapane, K, et al. Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord 1998;9:347–56.
39.Minimum Data Set Plus Training Manual. Natick, MA: Eliot Press; 1991.
40.Hawes, C, Morris, JN, Phillips, CD, Mor, V, Fries, BE, Nonemaker, S. Reliability estimates for the Minimum Data Set for Nursing Home Resident Assessment and care screening (MDS) Gerontologist 1995; 2:172–8.
41.Morris, JN, Nonemaker, S, Murphy, K, et al. A commitment to change: revision of the HCFA's RAI. J Am Geriatr Soc 1997;45:1011–6.
42.Sgadari, A, Morris, JN, Fries, BE, et al. Effort to establish the reliability of the RAI. Age Ageing 1997;26:27–30.
43.Hawes, C, Phillips, CD, Mor, V, et al. The OBRA-87 nursing home regulations and implementation of the Resident Assessment Instrument: effects on process quality. J Am Geriatr Soc 1997;45:977–85.
44.Fries, BE, Hawes, C, Morris, JN, Phillips, CD, Mor, V, Park, PS. Effect of the national Resident Assessment Instrument on selected health conditions and problems. J Am Geriatr Soc 1997;45:994–1001.
45.Mor, V, Intrator, O, Fries, BE, et al. Changes in hospitalization associated with introducing the resident assessment instrument. J Am Geriatr Soc 1997;45:1002–10.
46.Phillips, C, Morris, JN, Hawes, C, et al. Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status. J Am Geriatr Soc 1997;45:986–93.
47.Morris, JN, Fries, BE, Mehr, DR et al. MDS Cognitive Performance Scale. J Gerontol 1994;49:M174–82.
48.Mor, V, Branco, K, Fleishman, J, et al. The structure of social engagement among nursing home residents. J Gerontol 1995;50B:P1–8.
49.Voelkl, JE, Fries, BE, Galecki, AT. Predictors of nursing home resident's participation in activity programs. Gerontologist 1995;35:44–51.
50.Blaum, CS, O'Neill, EF, Clements, KM, Fries, BE, Fiatarone, MA. Validity of the Minimum Data Set for assessing nutritional status in nursing home residents. Am J Clin Nutr 1997;66:787–94.
51.Williams, BC, Li, Y, Fries, BE, Warren, RL. Predicting patient scores between the Functional Independence measure and the Minimum Data Set: development and performance of a FIM-MDS “crosswalk”. Arch Phys Med Rehabil 1997;78:48–54.
52.Resnick, HE, Fries, BE, Verbrugge, LM. Windows to their world: the effect of sensory impariments on social engagement and activity time in nursing home residents. J Gerontol Soc Sci 1997;52:S135–44.
53.Resnick, NM, Brandeis, GH, Baumann, MM, Morris, JN. Evaluating a national assessment strategy for urinary incontinence in nursing home residents: reliability of the Minimum Data Set and validity of the Resident Assessment Protocol. Neurourol Urodyn 1996;15:583–98.
54.Fried, TR, Mor, V. Frailty and hospitalization of long-term stay nursing home residents. J Am Geriatr Soc 1997;45:265–9.
55.Hartmaier, SL, Sloane, PD, Guess, HA, Koch, GG. The MDS cognition scale: a valid instrument for identifying and staging nursing home residents with dementia using the Minimum Data Set. J Am Geriatr Soc 1994;42:1173–9.
56.Hartmaier, SL, Sloane, PD, Guess, HA, Koch, GG, Mitchell, CM, Phillips, CD. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol Med Sci 1995;50:M128–33.
57.Frederiksen, K, Tariot, P, De, Jonghe E. Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales. J Am Geriatr Soc 1996;44:305–9.
58.Fries, BE, Schneider, DP, Foley, WJ, Gavazzi, M, Burke, R, Cornelius, E. Refining a case-mix measure for nursing homes: resource utilization groups (RUG-III). Med Care 1994;32:668–85.
59.Fries, BE, Mehr, DR, Schneider, D, Foley, WJ, Burke, R. Mental dysfunction and resource use in nursing homes. Med Care 1993;31:898–920.
60.Master Drug Data Base (MDDB) Documentation manual. Indianapolis, IN: MediSpan Inc.; 1995.
61.Massachussets Extended Care Federation Survey, Certification and Enforcement. The Long-Term Care Survey Regulations, Forms, Intepretative Guidelines. Dedham, MA, 1995.
62.Zinn, JS, Mor, V. Nursing home special care units: distribution by type, state and facility characteristics. Gerontologist 1994;34:371–7.
63.Banaszak-Holl, J, Zinn, JS, Mor, VThe impact of market and organizational characteristics on nursing care facility service innovation: a resource dependency perspective. Health Serv Res 1996;31:97–117.
64.Stambler, H. The Area Resource File: a brief look. Public Health Reports 1988;103:184–8.
65.Stafford, RS, Saglam, D, Blumenthal, D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157:2460–4.
66.McDermott, MM, Feinglass, J, Lee, P, et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. Am Heart J 1997;134:901–9.
67.Rich, MW, Brooks, K, Luther, P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990–1995. Am Heart J 1998:135:367–72.
68.The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429–35.
69.SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.
70.Garg, R, Yusuf, S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995:273:1450–6.
71.Newman, J, Ahmed, O, Hyngstrom, T, et al. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157:1103–8.
72.Deedwania, PC. Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve. Arch Intern Med 1997;157:2409–12.
73.Wennberg, JE, Freeman, JL, Shelton, RM, et al. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med 1989:321:1168–73.
74.Wennberg, JE. The geography of health care in the United States. In: Wennberg, JE, McAndrew, Cooper M, eds. The Dartmouth atlas of health care. Chicago, IL: American Hospital Publishing, Inc.; 1996:11–35.
75.Philbin, EF, Andreaou, C, Rocco, TA, Lynch, LJ, Baker, SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832–8.
76.Raleigh, VS. The demographic timebomb. BMJ 1997;315:442–3.
77.Redelmeier, DA, Tan, SH, Booth, GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516–20.
78.Kane, RL. Improving the quality of long-term care. JAMA 1995;273:1376–80.
79.Institute of Medicine. Health outcomes for older people. JC, Feasley, ed. Washington DC: National Academic Press, 1996.
80.Epstein, RS, Sherwood, LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996;124:832–7.
81.Hunter, DJ, Fairfield. Disease management. BMJ 1997;314:50–3.
82.Phillips, CD, Sloane, PD, Hawes, C, et al. Effects of residence in Alzheimer disease special care units on functional outcomes. JAMA 1997;278:1340–4.
83.Zimmerman, DR, Karon, SL, Arling, G, et al. Developing and testing of nursing home quality indicators. Health Care Financing Review 1995;16(4):107–27.
84.Berlowitz, DR, Brandeis, GH, Moskowitz, MA. Using administrative databases to evaluate long-term care. J Am Geriatr Soc 1997;45:618–23.
85.Bradley, EH, Besdine, R. Outcomes-based quality improvement: reducing the data collection burden. J Am Geriatr Soc 1998;46:534–5.
86.Teresi, JA, Holmes, D. Should MDS data be used for research? Gerontologist 1992;32:148–9.
87.Ouslander, JG. Maximizing the Minimum Data Set. J Am Geriatr Soc 1994;42:1212–3.
88.Black, D, Bowman, C. Community institutional care for frail elderly people. BMJ 1997;315:441–2.
89.Schroll, M. Effects of systematic geriatric assessment. Lancet 1997;350:604–5.
90.Steel, K. Research on aging: an agenda for all nations individually and collectively. JAMA 1997;278:1374–5.
91.Fries, BE, Schroll, M, Hawes, C, Gilgen, R, Jonsson, PV, Park, P. Approaching cross-national comparisons of nursing home residents. Age Ageing 1997;26(suppl. 2):13–8.
92.Phillips, CD, Hawes, C, Mor, V, Fries, BE, Morris, JN, Nennstiel, ME. Facility and area variation affecting the use of physical restraints in nursing homes. Med Care 1996;34:1149–62.
93.Gatsonis, CA, Epstein, AM, Newhouse, JP, Normand, SL, McNeil, BJ. Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction. Med Care 1995;33:625–42.